April 10, 2018 / 11:57 PM / 13 days ago

BRIEF-Novartis Drug Afinitor Disperz Receives FDA Approval To Treat TSC-Associated Partial Onset Seizures

April 10 (Reuters) - Novartis AG:

* NOVARTIS DRUG AFINITOR DISPERZ® RECEIVES FDA APPROVAL TO TREAT TSC-ASSOCIATED PARTIAL - ONSET SEIZURES

* AFINITOR DISPERZ RECEIVES FDA APPROVAL TO TREAT TSC-ASSOCIATED PARTIAL-ONSET SEIZURES Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below